Dashboard
Manage Tickers

ENOV Enovis CORP

NYSE enovis.com


$ 31.26 $ 0.55 (1.79 %)    

Friday, 31-Oct-2025 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 31.24
$ 30.34
$ 29.00 x 125
$ 35.00 x 18
$ 29.76 - $ 31.30
$ 25.47 - $ 49.83
960,695
na
1.79B
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 07-04-2025 10-Q
2 05-08-2025 04-04-2025 10-Q
3 02-26-2025 12-31-2024 10-K
4 11-06-2024 09-27-2024 10-Q
5 08-07-2024 06-28-2024 10-Q
6 05-02-2024 03-29-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 11-07-2023 09-29-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-04-2022 07-01-2022 10-Q
14 05-10-2022 04-01-2022 10-Q
15 02-22-2022 12-31-2021 10-K
16 11-04-2021 10-01-2021 10-Q
17 07-28-2021 07-02-2021 10-Q
18 04-29-2021 04-02-2021 10-Q
19 02-18-2021 12-31-2020 10-K
20 10-29-2020 10-02-2020 10-Q
21 08-06-2020 07-03-2020 10-Q
22 05-07-2020 04-03-2020 10-Q
23 02-24-2020 12-31-2019 10-K
24 10-31-2019 09-27-2019 10-Q
25 08-06-2019 06-28-2019 10-Q
26 05-08-2019 03-29-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 10-25-2018 09-28-2018 10-Q
29 08-06-2018 06-29-2018 10-Q
30 05-03-2018 03-30-2018 10-Q
31 02-16-2018 12-31-2017 10-K
32 11-06-2017 09-29-2017 10-Q
33 07-28-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 02-14-2017 12-31-2016 10-K
36 10-27-2016 09-30-2016 10-Q
37 07-28-2016 07-01-2016 10-Q
38 05-03-2016 04-01-2016 10-Q
39 02-16-2016 12-31-2015 10-K
40 10-22-2015 09-25-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-enovis-lowers-price-target-to-58
Canaccord Genuity Maintains Buy on Enovis,...
08/08/2025 21:10:52

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $70 to $58.

ubs-maintains-buy-on-enovis-lowers-price-target-to-57
UBS Maintains Buy on Enovis, Lowers Price ...
08/08/2025 18:35:33

UBS analyst Danielle Antalffy maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $65 to $57.

wells-fargo-maintains-overweight-on-enovis-lowers-price-target-to-41
Wells Fargo Maintains Overweight on Enovis...
08/08/2025 15:21:22

Wells Fargo analyst Vik Chopra maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $48 to $41.

enovis-raises-fy2025-adj-eps-guidance-from-295-310-to-305-320-vs-303-est-raises-fy2025-sales-guidance-from-2220b-2250b-to-2245b-2275b-vs-2236b-est
Enovis Raises FY2025 Adj EPS Guidance from...
08/07/2025 10:04:13

2025 Financial OutlookEnovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.245-2.275 bi...

enovis-q2-adj-eps-079-beats-071-estimate-sales-564545m-beat-554613m-estimate
Enovis Q2 Adj. EPS $0.79 Beats $0.71 Estim...
08/07/2025 10:01:07

Enovis (NYSE:ENOV) reported quarterly earnings of $0.79 per share which beat the analyst consensus estimate of $0.71 by 10.49 p...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

jehoshaphat-research-posts-on-x-we-are-short-enovis-enov-a-roll-up-of-health-care-businesses-thats-easy-to-borrow-below-is-just-a-summary-of-the-key-opinions-in-this-idea-for-the-full-short-thesis-including-a-downloadable-pdf-please-see-the-jehoshaphat-research-site
Jehoshaphat Research Posts On X "We are sh...
07/17/2025 13:45:50

https://x.com/jehoshaphatrsch/status/1945841045884875234?s=46&t=dtUiyC3dUs5yGRgT9qYHWg

assessing-enovis-insights-from-4-financial-analysts
Assessing Enovis: Insights From 4 Financia...
07/08/2025 13:00:49

evercore-isi-group-maintains-outperform-on-enovis-lowers-price-target-to-46
Evercore ISI Group Maintains Outperform on...
07/08/2025 12:56:12

Evercore ISI Group analyst Vijay Kumar maintains Enovis (NYSE:ENOV) with a Outperform and lowers the price target from $48 t...

canaccord-genuity-maintains-buy-on-enovis-lowers-price-target-to-70
Canaccord Genuity Maintains Buy on Enovis,...
05/14/2025 15:42:32

Canaccord Genuity analyst Caitlin Cronin maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $75 to $70.

where-enovis-stands-with-analysts
Where Enovis Stands With Analysts
05/09/2025 21:00:46

jmp-securities-maintains-market-outperform-on-enovis-lowers-price-target-to-55
JMP Securities Maintains Market Outperform...
05/09/2025 14:52:48

JMP Securities analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from ...

needham-maintains-buy-on-enovis-lowers-price-target-to-57
Needham Maintains Buy on Enovis, Lowers Pr...
05/09/2025 10:13:59

Needham analyst Mike Matson maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $64 to $57.

enovis-lowers-fy2025-adj-eps-guidance-from-310-325-to-295-310-vs-318-est-raises-fy2025-sales-guidance-from-219b-222b-to-222b-225b-vs-221b-est
Enovis Lowers FY2025 Adj EPS Guidance from...
05/08/2025 10:06:05

Enovis updated financial expectations for 2025. Revenue is expected to be in the range of $2.22-2.25 billion, versus prior expe...

enovis-q1-2025-adj-eps-081-beats-074-estimate-sales-55883m-miss-55890m-estimate
Enovis Q1 2025 Adj. EPS $0.81 Beats $0.74 ...
05/08/2025 10:03:20

Core News & Articles
Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

needham-reiterates-buy-on-enovis-maintains-64-price-target
Needham Reiterates Buy on Enovis, Maintain...
04/09/2025 13:02:36

Needham analyst Mike Matson reiterates Enovis (NYSE:ENOV) with a Buy and maintains $64 price target.

needham-reiterates-buy-on-enovis-maintains-64-price-target
Needham Reiterates Buy on Enovis, Maintain...
04/02/2025 16:11:51

Needham analyst Mike Matson reiterates Enovis (NYSE:ENOV) with a Buy and maintains $64 price target.

enovis-appoints-damien-mcdonald-as-ceo-effective-may-12-2025-following-matt-trerotolas-retirement
Enovis Appoints Damien McDonald as CEO, Ef...
04/02/2025 10:34:57

Enovis also reiterated its expectations for first quarter revenues to be in the range of $555 to $563 million and adjusted EBIT...

needham-maintains-buy-on-enovis-lowers-price-target-to-64
Needham Maintains Buy on Enovis, Lowers Pr...
02/27/2025 10:06:36

Needham analyst Mike Matson maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $65 to $64.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION